Clinical Psychopharmacology for Psychologists
4
2014-2015
01741180
Psychology
Portuguese
English
Face-to-face
6.0
Elective
1st Cycle Studies
Recommended Prerequisites
NA
Teaching Methods
Videos are used, practices and group discussions with review of practices, texts or other material, and exposition by the teacher. Emphasis is given to the presentation of clinical cases.
Learning Outcomes
Introducing Psychology students in the context of prescription and therapeutic use of psychotropic drugs, emphasizing the aspects of psychological profession.
Moreover, they should acquire the necessary knowledge about the different types of drugs and drug groups used in the handling of psychological disorders, its complexity of action, therapeutic indications, psychological mechanisms associated with its action, adverse reactions, and other hangover symptoms, of potentially interest in the practice of psychology. The contents of this course are reported in the context of an integrated psychological model. It uses a model-based psychopharmacology drugs (Moncrieff & Cohen, 2005).
Work Placement(s)
NoSyllabus
HISTORY OF MODERN Psychopharmacology
BRIEF INTRODUCTION TO Pharmacokinetics And Pharmacodynamics
Central Nervous System Depressants
barbiturates
Benzodiazepines and anxiolytics of SECOND-GENERATION
OTHER
STIMULATING THE CENTRAL NERVOUS SYSTEM
ULITIZADAS DRUGS IN THE TREATMENT OF PSYCHOLOGICAL DISORDERS
Antidepressants
THE STABILIZATION OF HUMOR
The ANTIPSYCHOTICS
Psychopharmacology CHILDREN AND YOUTH
psychopharmacology GERIÁTICA
OS herbal treatments
INTEGRATING THE TREATMENT CLINICAL AND PSYCHOLOGICAL TREATMENTS
MODEL FOCUSED ON THE DISEASE MODEL FOCUSED ON DRUGS
Head Lecturer(s)
Carlos Manuel Lopes Pires
Assessment Methods
Assessment
Exam: 100.0%
Bibliography
Bezchlibnyk-Butler, K., & Jeffries, J. (2002). Clinical Handbook of Psychotropic Drugs. Twelfth revised edition. Toronto: Hogrefe & Huber Publishers
Kirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. S. (2002a). The emporer's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention & Treatment, 5, Article 23. Disponível na internet: http://www.journals.apa.org/prevention/volume5/pre0050023a.html
Moncrief, J. & Cohen, D. (2004). RETHINKING MODELS OF PSYCHOTROPIC DRUG ACTION. Psychotherapy and Psychosomatics 2005;74:145-153
Pettit, J. W., Zachary, R. V., & Joiner, T. E. (2001). Combined treatments for depression. In M. T. Sammons, & N. B. Schmidt, (Eds). Combined treatments for mental disorders: a guide to psychological and pharmacological interventions. Phelps,L.,Brown,R.T.,&Power,T.J.(2002).Pediatric Psychopharmacology:Combining Medical and Psychosocial Interventions.Washington DC,American Psychological Association